Molecular action of androgens and structure-function relationships of androgen receptor;Action moleculaire des androgenes et relation structure-fonction du recepteur des androgenes

Medecine/Sciences

Volumn 16, Issue 6-7, 2000, Pages 793-802

  Poujol, Nicolas ^a,b,c   Sultan, Charles ^a,b,d  

^a INSERM   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

DNA SEQUENCE; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; PROTEIN DNA INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0033924005     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1732     Document Type: Review

References (51)

1. Sultan C, Lobaccaro JM. Génétique moléculaire des syndromes d'insensibilité aux androgènes. Med Sci 1991; 7: 697-704.
2. Sultan C, Savage MO. Intersex states. In: G.A.B. Clinical endocrinology. London: 1998: 796-809.
3. Quigley CA, Debellis A, Marschke KB, Elawady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Rev 1995; 16: 271-321.
4. Mangelsdorf D, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-9.
5. Sapakar PC, Song CS, Jung MH, et al. A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. J Biol Chem 1993; 268: 26400-8.
6. LeDai J, Burnstein KL. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Mol Endocrinol 1996; 10: 1582-94.
7. Nirdé P, Georget V, Térouanne B, Galifer RB, Belon C, Sultan C. Quantification of androgen receptor messenger RNA from genital skin fibroblasts by reverse transcription-competitive polymerase chain reaction. J Steroid Biochem Mol Biol 1998; 66: 35-43.
8. Moras D, Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 1998; 10: 384-91.
9. Nolte RT, Wisely GB, Westin S, et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 1998; 395: 137-43.
10. Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/ coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998; 95: 927-37.
11. Wurtz JM, Bourguet W, Renaud JP, et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 1996; 3: 87-94
12. Fagart J, Wurtz JM, Souque A, Hellal LC, Moras D, Rafestin OM. Antagonism in the human mineralocorticoid receptor. EMBO J 1998; 17: 3317-25.
13. Poujol N, Wurtz JM, Tahiri B, Lumbroso S, Nicolas JC, Moras D, Sultan C. Specific recognition of androgens by their nuclear receptor: a structure-function study. J Biol Chem 2000 (sous presse).
14. Renaud JP, Rochel N, Ruff M, et al. Crystal structure of the RAR-gamma liquid-binding domain bound to all-trans retinoic acid. Nature 1995; 378: 681-9.
15. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. The androgen receptor gene mutations database. Nucleic Acids Res 1998; 26: 234-8.
16. Veldscholte J, Berrevoets CA, Zegers ND, Vanderkwast TH, Grootegoed JA, Mulder K. Hormone-induced dissociation of the androgen receptor-heat-shock protein complex - use of a new monoclonal antibody to distinguish transformed from nontransformed receptors. Biochemistry 1992; 31: 7422-30.
17. Kuil CW, Berrevoets CA, Mulder K. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action. J Biol Chem 1995; 270: 27569-76.
18. Kuiper GGJM, Brinkmann AO. Phosphotryptic peptide analysis of the human androgen receptor: detection of a hormone-induced phosphopeptide. Biochemistry 1995; 34: 1851-7.
19. Tremblay A, Tremblay GB, Labrie F, Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 1999; 3: 513-9.
20. Hammer GD, Krylova I, Zhang Y, et al. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol Cell 1999; 3: 521-6.
21. Görlich D. Transport into and out of the cell nucleus. EMBO J 1998; 17: 2721-7.
22. Roche PJ, Hoare SA, Parker MG. A consensus DNA-Binding site for the androgen receptor. Mol Endocrinol 1992; 6: 2229-35.
23. Fabre S, Manin M, Pailhoux F, Veyssière G, Jean C. Identification of a functional androgen response element in the promoter of the gene for the androgen-regulated aldose reductase-like protein specific to the mouse vas deferent. J Biol Chem 1994; 269: 5857-64.
24. Haelens A, Verrijdt G, Schoenmakers E, et al. The first exon of the human sc gene contains an androgen responsive unit and an interfeion regulatory factor element. Mol Cell Endocrinol 1999; 153: 91-102.
25. Freedman LP. Anatomy of the steroid receptor zinc finger region. Endocrine Rev 1992; 13: 129-45.
26. Lobaccaro JM, Poujol N, Chiche L, Lumbroso S, Brown TR, Sultan C. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol Cell Endocrinol 1996; 116: 137-47.
27. Poujol N, Lobaccaro J, Chiche L, Lumbroso S, Sultan C. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol 2000 (sous presse).
28. Chen S, Wang J, Yu GQ, Liu W, Pearce D. Androgen and glucocorticoid receptor heterodimer formation. Proc Natl Acad Sci USA 1997; 272: 14087-92.
29. Eriksson P, Wrange O. Protein-protein contacts in the glucocorticoid receptor homodimer influence its DNA binding properties. J Biol Chem 1990; 265: 3535-42.
30. McEwan IJ, Gustafsson J. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc Natl Acad Sci USA 1997; 94: 8485-90.
31. Ford J, McEwan IJ, Wright AP, Gustafsson JA. Involvement of the transcription factor IID protein complex in gene activation by the N-terminal transactivation domain of the glucocorticoid receptor in vitro. Mol Endocrinol 1997; 11: 1467-75.
32. Jacq X, Brou C, Lutz Y, Davidson I, Chambon P, Tora L. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 1994; 79: 107-17.
33. Torchia J, Glass C, Rosenfeld MG. Coactivators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 1998; 10: 373-83.
34. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocrinol Rev 1999; 20: 321-44.
35. Ding XF, Anderson CM, Ma H et al. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 4 (SRC- 1): multiple motifs with different binding specificities. Mol Endocrinol 1998; 12: 302-13.
36. Ikonen T, Palvimo JJ, Janne OA. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 1997; 272: 29821-8.
37. Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol 1998; 12: 1172-83.
38. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998; 279: 1922-5.
39. Yeh S, Chang C. Cloning and characterisation of a specific coactivator, Ara70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996; 93: 5517-21.
40. Alen P, Claessens F, Schoenmakers E, et al. Interaction of the putative androgen receptor-specific coactivator ARA70/ ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 1999; 13: 117-28.
41. Froesch BA, Takayama S, Reed JC. BAG-1L, protein enhances androgen receptor function. J Biol Chem 1998; 273: 11660-6.
42. Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA, Palvimo JJ. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol 1998; 18: 5128-39.
43. Lanz RB, McKenna NJ, Onate SA, et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 1999; 97: 17-27.
44. Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol/1997; 11: 693-705.
45. Smith CL, Nawas Z, O'Malley BW. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 1997; 11: 657-66.
46. Bubulya A, Wise SC, Shen XQ, Burmeister LA, Shemshedini L. c-Jun can mediate androgen receptor-induced transactivation. J Biol Chem 1996; 271: 24583-9.
47. Aarnisalo P, Palvimo JJ, Jaune OA. CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci USA 1998; 95: 2122-7.
48. Lobaccaro JM, Poujol N, Terouanne B, et al. Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1: dissection of the androgen receptor functional domains. Endocrinology 1999; 140: 350-7.
49. Culig Z, Hobisch A, Cronamer MV, et al. Androgen receptor activation in prostatic tumor cell lines by insulin- like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994; 54: 5474-8.
50. Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999; 5: 280-5.
51. Térouanne B, Tahisi B, Georget V, Belou C, Poujol N, Avances C, Orio F Jr, Balaguer P, Sultan C. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol Cell Endocrinol 2000; 160: 39-49.